| Date | Title | Description |
| 06.11.2024 | Navamedic ASA: Mandatory notice of trade | Navamedic ASA: Mandatory notice of trade
Wed, Nov 06, 2024 13:52 CET Report this content
Oslo, November 6, 2024: Lars Hjarrand, CFO and a primary insider of Navamedic ASA, has today bought 20.000 Navamedic ASA shares at an average price of ... |
| 06.11.2024 | Navamedic launches Eroxon[®] in Finland | Navamedic launches Eroxon[®] in Finland
Wed, Nov 06, 2024 09:10 CET Report this content
Oslo, 6 November 2024 – Building on the successful product launch of Eroxon® in Norway and Sweden earlier this year, Navamedic ASA (OSE: NAVA), a Nordic... |
| 01.11.2024 | Navamedic's Q3 2024: Navigating Challenges with Resilience | In the world of pharmaceuticals, the tides can shift quickly. Navamedic ASA, a Nordic pharmaceutical company, recently released its third-quarter results for 2024. The numbers tell a story of resilience amid cyclical challenges. For the qua... |
| 31.10.2024 | Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business | Navamedic Q3 2024: Business remains strong in quarter impacted by cyclical nature of the business
Thu, Oct 31, 2024 07:00 CET Report this content
Oslo, 31 October 2024 – In the third quarter of 2024, Navamedic ASA (OSE: NAVA), a Nordic phar... |
| 28.10.2024 | Navamedic ASA: Invitation to 2024 3rd quarter presentation | Navamedic ASA: Invitation to 2024 3rd quarter presentation
Mon, Oct 28, 2024 09:08 CET Report this content
Oslo, October 28, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 3rd quarter 2024 results on Thursday, October 31st, 2024. T... |
| 07.10.2024 | Navamedic wins joint Nordic antibiotics tender | Navamedic wins joint Nordic antibiotics tender
Mon, Oct 07, 2024 13:56 CET Report this content
Oslo, 07 October 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharma... |
| 15.09.2024 | A Digital Lifeline: Alex Therapeutics and Navamedic Unite for Parkinson’s Care | In a world where technology meets healthcare, a new partnership is emerging. Alex Therapeutics and Navamedic have joined forces to develop a Companion App aimed at transforming the treatment landscape for Parkinson’s disease. This collabora... |
| 12.09.2024 | Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease | Navamedic announces an exclusive agreement with Alex Therapeutics for the development of a Companion App to aid in the treatment of Parkinson’s Disease
Thu, Sep 12, 2024 12:00 CET Report this content
Stockholm Sweden, September 12, 2024 - N... |
| 12.09.2024 | Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion App to aid in the treatment of Parkinson’s Disease | Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion App to aid in the treatment of Parkinson’s Disease
Thu, Sep 12, 2024 12:00 CET Report this content
Stockholm Sweden, September 12, 2024 - ... |
| 10.09.2024 | Navamedic ASA: A Strategic Move in Share Capital Expansion | On September 9, 2024, Navamedic ASA made headlines with a significant decision to increase its share capital. This move, rooted in the exercise of employee options, signals a strategic pivot for the company. The board of directors approved ... |
| 09.09.2024 | NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS | NAVAMEDIC ASA: RESOLUTION TO INCREASE THE SHARE CAPITAL IN CONNECTION WITH EXERCISE OF EMPLOYEE OPTIONS
Mon, Sep 09, 2024 16:03 CET Report this content
Oslo, 9 September 2024: The board of directors of Navamedic ASA (the "Company"... |
| 09.09.2024 | Navamedic ASA – Mandatory notification of trade by primary insider | Navamedic ASA – Mandatory notification of trade by primary insider
Mon, Sep 09, 2024 16:47 CET Report this content
Oslo, 9 September 2024: Reference is made to the stock exchange announcement published earlier today, on 9 September 2024 by ... |
| 16.08.2024 | Navamedic's Steady Ascent: A Look at Q2 and H1 2024 Performance | In the world of pharmaceuticals, stability is a rare gem. Navamedic ASA, a Nordic pharmaceutical company, has polished this gem through its recent performance in the first half of 2024. The company reported revenues of NOK 277.2 million, ma... |
| 16.08.2024 | Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement | Navamedic Q2 and H1 2024: Stable growth continues and is supported by a new licensing and supply agreement
Fri, Aug 16, 2024 07:00 CET Report this content
Oslo, 16 August 2024 – In first half of 2024, Navamedic ASA (OSE: NAVA), a Nordic pha... |
| 12.08.2024 | Navamedic ASA: Invitation to 2024 2nd quarter presentation | Navamedic ASA: Invitation to 2024 2nd quarter presentation
Mon, Aug 12, 2024 10:00 CET Report this content
Oslo, August 12, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 2nd quarter/1st half 2024 results on Friday, August 16, 2024... |
| 24.06.2024 | Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe | Navamedic and Orion Corporation sign License & Supply Agreement for Flexilev® in Europe
Mon, Jun 24, 2024 16:19 CET Report this content
Oslo, 24 June 2024 - Navamedic ASA and Orion Corporation (“Orion”) have today signed a license and s... |
| 04.06.2024 | Navamedic ASA: Minutes of Annual General Meeting | Navamedic ASA: Minutes of Annual General Meeting
Tue, Jun 04, 2024 10:18 CET Report this content
Oslo, 4 June 2024: The Annual General Meeting of Navamedic ASA was held today at 09:00 CEST. All items on the agenda were resolved in accordanc... |
| 16.05.2024 | Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals | Navamedic ASA: Renewed contract for delivering antibiotics to Norwegian hospitals
Thu, May 16, 2024 09:00 CET Report this content
Oslo, 16 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality p... |
| 14.05.2024 | Navamedic ASA: Notice of Annual General Meeting | Navamedic ASA: Notice of Annual General Meeting
Tue, May 14, 2024 14:10 CET Report this content
The annual general meeting of Navamedic ASA (OSE: NAVA) will be held on Tuesday, June 4th 2024 at 09:00 (CET) in the Navamedic offices in Henrik... |
| 06.05.2024 | Navamedic ASA: Broad launch for Eroxon® in Sweden today | Navamedic ASA: Broad launch for Eroxon® in Sweden today
Mon, May 06, 2024 11:00 CET Report this content
Oslo, 6 May 2024 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and ph... |
| 30.04.2024 | Navamedic ASA: Annual Report 2023 | Navamedic ASA: Annual Report 2023
Tue, Apr 30, 2024 17:45 CET Report this content
Oslo, 30 April 30 2024 - Navamedic ASA has today published its Annual Report for 2023 approved by the Board of Directors. Find enclosed the report in PDF as w... |
| 30.04.2024 | Navamedic Q1 2024: Successful product launch and steady operational progress | Navamedic Q1 2024: Successful product launch and steady operational progress
Tue, Apr 30, 2024 07:00 CET Report this content
Oslo, 30 April 2024 – In the first quarter 2024, Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable pr... |
| 23.04.2024 | Navamedic ASA: Invitation to 2024 1st quarter presentation | Navamedic ASA: Invitation to 2024 1st quarter presentation
Tue, Apr 23, 2024 14:30 CET Report this content
Oslo, April 23, 2024 - Navamedic ASA (OSE: Nava) will be presenting its 1st quarter 2024 results on Tuesday, April 30, 2024. The pres... |
| 15.03.2024 | Navamedic ASA – Mandatory notification of trade by primary insider | Navamedic ASA – Mandatory notification of trade by primary insider
Fri, Mar 15, 2024 13:30 CET Report this content
Oslo, 15 March 2024: Reference is made to the stock exchange announcement published earlier today, on 15 March 2024 by Navame... |
| 15.03.2024 | Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options | Navamedic ASA: Resolution to increase the share capital in connection with exercise of employee options
Fri, Mar 15, 2024 11:51 CET Report this content
Oslo, 15 March 2024: The board of directors of Navamedic ASA (the "Company"), ... |
| 30.08.2023 | Navamedic ASA – Registration of share capital increase | Navamedic ASA – Registration of share capital increase
Wed, Aug 30, 2023 13:02 CET Report this content
Oslo, 30 August 2023: Reference is made to the stock exchange announcement published on 18 August 2023 by Navamedic ASA (the "Compan... |
| 07.08.2023 | Navamedic ASA: Invitation to 2023 2nd quarter presentation | Navamedic ASA: Invitation to 2023 2nd quarter presentation
Mon, Aug 07, 2023 12:24 CET Report this content
Oslo, August 7, 2023 - Navamedic ASA (OSE: Nava) will be presenting its second quarter 2023 results and publish its first half 2023 r... |
| 01.06.2023 | Navamedic ASA: Minutes of Annual General Meeting | Navamedic ASA: Minutes of Annual General Meeting
Thu, Jun 01, 2023 11:35 CET Report this content
Oslo, 1 June 2023: The Annual General Meeting of Navamedic ASA was held today at 10:00 CEST. All items on the agenda were resolved in accordanc... |
| 31.05.2023 | Updated recommendation by the nomination committee of Navamedic ASA | Updated recommendation by the nomination committee of Navamedic ASA
Wed, May 31, 2023 14:16 CET Report this content
Following Navamedic ASA’s acquisition of Sensidose AB, the nomination committee recommends that Åsa Kornfeld, previous Board... |
| 26.05.2023 | Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer | Navamedic to own a total of 96.33 per cent of shares in Sensidose following closing of public offer
Fri, May 26, 2023 08:00 CET Report this content
Oslo, 26 May 2023 – Following the closing of the acceptance period in the previously announc... |
| 11.05.2023 | Navamedic ASA Q1 2023: Another strong quarter | Navamedic ASA Q1 2023: Another strong quarter
Thu, May 11, 2023 08:00 CET Report this content
Oslo, 11 May 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies,... |
| 08.05.2023 | Navamedic ASA: Invitation to 2023 1st quarter presentation | Navamedic ASA: Invitation to 2023 1st quarter presentation
Mon, May 08, 2023 10:41 CET Report this content
Oslo, May 8, 2023 - Navamedic ASA (OSE: Nava) will be presenting its first quarter 2023 results on Thursday May 11, 2023. The present... |
| 28.04.2023 | Navamedic ASA: Annual Report for 2022 | Navamedic ASA: Annual Report for 2022
Fri, Apr 28, 2023 13:20 CET Report this content
Oslo, 28 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies, annou... |
| 25.04.2023 | Navamedic ASA expands its offer to include warrants of series TO 1 issued by Sensidose Aktiebolag at a price of SEK 0.38 in cash per warrant of series TO 1 | Navamedic ASA expands its offer to include warrants of series TO 1 issued by Sensidose Aktiebolag at a price of SEK 0.38 in cash per warrant of series TO 1
Tue, Apr 25, 2023 22:10 CET Report this content
This announcement is not an offer, w... |
| 22.04.2023 | Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB | Navamedic ASA: Amended cash offer to acquire Sensidose AB and acquisition of shares in Sensidose AB
Sat, Apr 22, 2023 13:10 CET Report this content
Oslo, 22 April 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of hig... |
| 22.04.2023 | Navamedic completes the offer, has entered into agreements to acquire approximately 56.7 per cent of the shares in Sensidose and increases the consideration to SEK 8 in cash per share | Navamedic completes the offer, has entered into agreements to acquire approximately 56.7 per cent of the shares in Sensidose and increases the consideration to SEK 8 in cash per share
Sat, Apr 22, 2023 13:00 CET Report this content
This ann... |
| 29.03.2023 | Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million | Navamedic ASA: Recommended cash offer to acquire Sensidose for approximately SEK 75 million
Wed, Mar 29, 2023 07:31 CET Report this content
Oslo, 29 March 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and provider of high-qualit... |
| 16.02.2023 | Navamedic ASA: Q4 2022 financial results | Navamedic ASA: Q4 2022 financial results
Thu, Feb 16, 2023 08:00 CET Report this content
Oslo, 16 February 2023 – Navamedic ASA (OSE: NAVA), a Nordic pharma company and reliable provider of high-quality products to hospitals and pharmacies,... |
| 13.02.2023 | Navamedic ASA: Invitation to 2022 4th quarter presentation | Navamedic ASA: Invitation to 2022 4th quarter presentation
Mon, Feb 13, 2023 09:00 CET Report this content
Oslo, February 13, 2023 - Navamedic ASA (OSE: Nava) will be presenting its fourth quarter 2022 results on Thursday February 16, 2023.... |
| 04.08.2022 | Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig® | Navamedic ASA – Exclusive agreement with Vectans Pharma for the unique cold sore treatment product Sitavig®
Thu, Aug 04, 2022 14:09 CET Report this content
Oslo, 4 August 2022 - Navamedic has signed an agreement with the French pharmaceutic... |
| 10.05.2022 | Navamedic ASA: Q1 2022 financial results | Navamedic ASA: Q1 2022 financial results
Tue, May 10, 2022 08:00 CET Report this content
Oslo, 10 May 2022 - Navamedic ASA (OSE: NAVA), a Nordic pharma company and
reliable provider of high-quality products to hospitals and pharmacies, grew... |
| 01.06.2021 | Navamedic ASA: Launch of new products strengthen the category of Medical Nutrition | Navamedic ASA: Launch of new products strengthen the category of Medical Nutrition Tue, Jun 01, 2021 09:51 CET
Oslo June 1th, 2021 – Navamedic ASA (“Navamedic”, OSE: NAVA) announces the launch of new products in the Nordics.
Medical Nutriti... |
| 20.05.2021 | Obesity patient support program launched in Norway | Obesity patient support program launched in Norway Thu, May 20, 2021 11:53 CET
Today Navamedic launches MyControl Support in Norway, a free-of-charge patient support program in collaboration with Observia, following a successful launch in S... |
